#PeerView

Tune in today to watch Cracking the HER2 Code in GI Cancers, a #PeerView #MedEd activity with Amy Brownlee, MD, and Elena Elimova, MD, MSc, FRCPC: #GastricCancer #GISM #Oncology #Pathology #GEA #BTC

#PeerView Live at #USCAP2020: @smlungpathguy giving an excellent practical talk about the nuances of PD-L1 expression testing and interpretation in current pathology practice. @PeerView

#PeerView Live at #USCAP2020: Kurt Schalper has kicked off an exciting #Immunotherapy #biomarkers symposium w/ @smlungpathguy and @PatelOncology bringing their #pathology and #ImmunoOncology expertise. Thanks to those who came early to learn! @PeerView

#PeerView Live at #USCAP2020: Dr. Kurt Schalper speaking very engagingly about the current best practices & new directions with MSI/MMR & TMB testing to identify candidates for cancer #immunotherapies. NGS for MSI? Will TMB play a role, or no? @PeerView

All agree that if you are on a #myeloma CD-38 monoclonal antibody, you will not mount a COVID antibody response. Evusheld can be helpful here. #mmsm #PeerView #ASCO22 @ninashah33 @myelomaMD @SagarLonialMD

Sunday Night @ #ASCO17 @DanielPetrylak & Drs. Balar and Dreicer. With @B_C_A_N #BladderCancer #PeerView See u there!

Dr. Omid Hamid (@OmidHamidMD) explores new #cancer #immunotherapy targets and combinations under investigation at #PeerView #AACR18 symposium

Bill Tap @sloan_kettering also discussed #selexinor in #liposarcoma. #PeerView #CTOS17

The team from ⁦⁦@MDAndersonNews⁩ ⁦@sanamloghavi⁩ ⁦@SaWangMD⁩ ⁦@Daver_Leukemia⁩ is here in full support #PeerView #ASCP2019

Dr Nathan reviewing interstitial lung abnormalities and prognosis #PeerView #ATS2017 ipf event

Join the experts at a #PeerView symposium on #PolycythemiaVera! See you at #ASH16 in San Diego on 12/2. #mpnsm

Rationale for combos overcoming btk resistance and cross resistance between classes #PeerView #ASH18

How do you select a second-line treatment for a patient with advanced #HepatocellularCarcinoma? Come hear Dr. Amit Singal’s considerations. #PeerView #ASCO19

Register now for #ASCO17 Sunday Symposium: Advances in Immunotherapy for #BladderCancer #PeerView

Mark Socinski analyzing results & implications of KEYNOTE-021 Cohort G. Which pts should receive this triplet in 1L NSCLC? #ASCO17 #PeerView

@DrChoueiri & experts expand on the #RCC treatment revolution – Live Now #PeerView #CME at #GU17

Dr Sagar Lonial now surveying the major studies testing novel triplets in relapsed #myeloma and discussing implications for post asct relapse ⁦@SagarLonialMD⁩ #PeerView #TCTM19

Dr Deborah Stephens now giving an overview of btk resistance across B-Cell cancers #PeerView #ASH19

Dr Nicola Longo summarizes benefits of Phe-restricted diet in adults with #PKU #PeerView #ACMGMtg18

Dr Ken Fujioka provides a closer look at potential alternatives to psychiatric agents associated weight gain #OW2017 #PeerView #meded

#PeerView #PKU symposium at #ACMGMtg18 underway. Barbara K. Burton, MD now discussing burden of this genetic disorder